Loading...

FITC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_FITC_082808.jpg
BALB/cmouse bone marrow cells stained with 1A8 FITC (gated on myeloid cells)
  • 1A8_FITC_082808.jpg
    BALB/cmouse bone marrow cells stained with 1A8 FITC (gated on myeloid cells)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
127605 50 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127606 500 µg 210€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Valladao A, et al. 2016. J Immunol. 197(12):4541-4551. PubMed
  2. Campbell IK, Leong D 2016. J Immunol. 197(11):4392-4402. PubMed
  3. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  4. Pohlmeier L, et al. 2021. Allergy. 76:2030. PubMed
  5. Li T, et al. 2022. J Exp Med. 219: . PubMed
  6. Yang Y, et al. 2022. FEBS J. 289:5279. PubMed
  7. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  8. Zhu Y, et al. 2023. J Ethnopharmacol. 301:115763. PubMed
  9. Xu Y, et al. 2023. EMBO Rep. 24:e55503. PubMed
  10. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  11. Pavliuchenko N, et al. 2023. Front Immunol. 13:1035226. PubMed
  12. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  13. Zong P, et al. 2022. Nat Cardiovasc Res. 1:344. PubMed
  14. Sanmarco LM, et al. 2022. Nature. 611:801. PubMed
  15. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  16. Le DT, et al. 2023. iScience. 26:106059. PubMed
  17. Veras FP, et al. 2023. Respir Res. 24:66. PubMed
  18. Doke T, et al. 2023. Nat Metab. 5:414. PubMed
  19. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  20. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  21. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  22. Park JA, et al. 2023. J Immunother Cancer. 11:. PubMed
  23. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  24. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  25. Silva BM, et al. 2023. J Clin Invest. 133:. PubMed
  26. Cui B, et al. 2023. Int Immunopharmacol. 120:110240. PubMed
  27. Oh J, et al. 2023. Nat Commun. 14:3278. PubMed
  28. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  29. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  30. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  31. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  32. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  33. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  34. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  35. Long M, et al. 2017. J Immunol. 198(2):862-872. PubMed
  36. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
  37. Mandraju R, et al. 2014. J Immunol. 192:4303. PubMed
  38. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  39. He R, et al. 2021. J Immunol. 206:2353. PubMed
  40. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  41. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  42. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  43. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  44. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  45. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  46. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  47. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  48. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  49. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  50. Patsalos A, et al. 2019. J Immunol. 203:1532. PubMed
  51. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  52. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  53. Torre S, et al. 2016. Nat Immunol. 10.1038/ni.3581. PubMed
  54. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  55. Wang C, et al. 2015. Sci Rep. 5: 14124. PubMed
  56. Han J, et al. 2022. FEBS J. 289:417. PubMed
  57. Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
  58. Huai W, et al. 2019. J Exp Med. 216:772. PubMed
  59. Castiglioni A, et al. 2015. PLoS One. 10:128094. PubMed
  60. Guesdon W, et al. 2015. J Infect Dis. 212: 1332 - 1340. PubMed
  61. Strother R, et al. 2016. J Immunol. 197(11):4301-4311. PubMed
  62. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  63. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  64. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  65. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  66. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  67. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  68. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  69. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  70. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  71. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  72. Han YH, et al. 2021. Science. 373:. PubMed
  73. Ueki H, et al. 2020. Nat Protoc. 15:1041. PubMed
  74. Saika A, et al. 2020. FASEB Bioadv. 2:59. PubMed
  75. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  76. Wang H et al. 2017. Developmental cell. 40(6):566-582 . PubMed
  77. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  78. Billi AC, et al. 2019. JCI Insight. 4:8. PubMed
  79. Abad C, et al. 2014. J Leukoc Biol. 95:357. PubMed
  80. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  81. Liu Z, et al. 2016. J Biol Chem. 291: 1441 - 1447. PubMed
  82. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  83. Na YR, et al. 2020. Cell Rep. 107643:31. PubMed
  84. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  85. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  86. Wu X, et al. 2021. Elife. 10:. PubMed
  87. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
  88. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  89. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
  90. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  91. Jacome-Galarza C, et al. 2011. J Bone Miner Res. 26:1207. PubMed
  92. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  93. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  94. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
  95. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  96. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  97. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  98. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  99. Minogue A, et al. 2014. Neurobiol Aging. 35:1442. PubMed
  100. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  101. Zheng J, et al. 2020. bioRxiv. . PubMed
  102. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  103. Geng S, et al. 2021. JCI Insight. 6:. PubMed
  104. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  105. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  106. Chen M, et al. 2021. Oncol Lett. 21:435. PubMed
  107. Huixin Xu et al. 2018. EMBO molecular medicine. 10(9) pii: e8931. PubMed
  108. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  109. Gousopoulos E, et al. 2016. Am J Pathol. 186:2193-2203. PubMed
  110. Radjabova V, et al. 2015. J Immunol. 195: 3149 - 3159. PubMed
  111. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  112. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  113. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  114. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  115. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  116. Roy K, et al. 2019. Immunity. 50:616. PubMed
  117. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  118. Christ A, et al. 2018. Cell. 172:162. PubMed
  119. Wu M, et al. 2013. Proc Natl Acad Sci U S A. 110:9439. PubMed
  120. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  121. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
  122. Shih Y, et al. 2015. JPEN J Parenter Enteral Nutr. . PubMed
  123. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  124. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  125. Flögel U, et al. 2021. Nat Commun. 12:5847. PubMed
  126. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  127. He J, et al. 2019. J Clin Invest. 130. PubMed
  128. Yu L, et al. 2019. Elife. 8:e46677. PubMed
  129. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  130. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  131. Zheng J, et al. 2020. Nature. . PubMed
  132. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  133. Fischer KJ, et al. 2019. J Immunol. 202:2027. PubMed
  134. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  135. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  136. Uderhardt S, et al. 2019. Cell. 177:541. PubMed
  137. Hermetet F, et al. 2019. Nat Commun. 10:523. PubMed
  138. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  139. Shevchenko MA, et al. 2018. J Immunol Res. 8:53. PubMed
  140. Simpson K, et al. 2012. J Immunol. 189:5533. PubMed
  141. Giampazolias E, et al. 2021. Cell. . PubMed
  142. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  143. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  144. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  145. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  146. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  147. Rebecca S Dickinson et al. 2017. Wellcome open research. 0.155555556 . PubMed
  148. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  149. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  150. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  151. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  152. Qin W, et al. 2022. Bio Protoc. 12:e4287. PubMed
  153. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  154. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  155. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  156. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  157. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  158. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  159. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
  160. Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed
  161. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  162. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  163. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  164. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  165. Makino A, et al. 2021. iScience. 24:103201. PubMed
  166. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  167. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  168. Thomas DG et al. 2018. Cell reports. 25(13):3774-3785 . PubMed
  169. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  170. Chen ST et al. 2019. Cell host & microbe. 25(4):602-616 . PubMed
  171. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  172. Wei Y, et al. 2021. Endocrinology. 162(8):. PubMed
  173. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  174. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  175. van Geffen C, et al. 2021. Front Immunol. 12:695933. PubMed
  176. Gu H, et al. 2021. Elife. 10:. PubMed
  177. Issah Y, et al. 2021. Elife. 10:. PubMed
  178. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  179. Danzer H, et al. 2020. Elife. 9:00. PubMed
  180. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  181. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  182. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  183. Chen J, et al. 2014. Cell Res. 24:1050. PubMed
  184. Xu Y, et al. 2014. Proc Natl Acad Sci U S A. 111:6371. PubMed
  185. Smith LK, et al. 2021. Elife. 10:. PubMed
  186. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  187. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  188. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  189. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  190. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  191. Stadtmann A, et al. 2015. J Immunol. 195: 1152-1161. PubMed
  192. Jia H, et al. 2016. J Immunol. 197: 859 - 871. PubMed
  193. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  194. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  195. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  196. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  197. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  198. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  199. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  200. Zhang H, et al. 2022. Commun Biol. 5:916. PubMed
  201. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  202. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  203. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  204. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
  205. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  206. Singh N, et al. 2016. Dis Model Mech. 9: 885 - 897. PubMed
  207. Cojohari O, Peppenelli M, Chan G 2016. Blood. 128: 529 - 541. PubMed
  208. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  209. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  210. Chuang LT, et al. 2021. Molecules. 26:. PubMed
  211. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
RRID
AB_1236488 (BioLegend Cat. No. 127605)
AB_1236488 (BioLegend Cat. No. 127606)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
Ly-6G
Specificity Alt (DOES NOT SHOW ON TDS):
Ly-6G
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Spark Red™ 718 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Spark Blue™ 574 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Go To Top Version: 3    Revision Date: 01-06-2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account